Tag: CARDIOVASCULAR

AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies
Artificial Intelligence Clinical Insights & Research Technology

AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies

A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]

Skimping on Sleep Leads to Weight Gain
Clinical Insights & Research

Skimping on Sleep Leads to Weight Gain

People who shortened their sleep by around 80 minutes a night for six weeks gained weight—one pound on average—and were more sedentary, researchers at Columbia University Vagelos College of Physicians and Surgeons have found. “Our study shows that getting adequate sleep may help reduce the risk of weight gain and obesity-related […]

LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study
Clinical Insights & Research Product News Sleep Apnea

LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study

Recently published study results demonstrate the efficacy of LivaNova Plc’s aura6000 System in treating moderate to severe obstructive sleep apnea (OSA). Published in Annals of Internal Medicine, the full 12-month results from the company’s OSPREY randomized controlled trial (RCT) demonstrate the safety and efficacy of proximal hypoglossal nerve stimulation (pHGNS), a differentiated neurostimulation modality. Overall, the study authors concluded that pHGNS for OSA yielded clinically significant improvements versus […]

New SANSA Platform Enhancements & Cardiovascular Risk Data to be Presented at SLEEP 2026
Industry News Sleep Apnea Technology

Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker

Huxley Medical, a commercial-stage medical technology company expanding access to sleep apnea testing across health systems, cardiology, and primary care, introduced two additions to its SANSA® platform: SANSA GO™, a point-of-care enrollment model that enables clinics to dispense SANSA at patient visits, and hypoxic burden, an additional measure of cardiovascular […]